Series D

Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.

Sodium-ion battery producer Natron, a Stanford spinout, has picked up corporates ABB and Chevron in a round bringing its lifetime funding to more than $70m.

McKesson Ventures came onboard for the health data provider Evidation's series D round, helping it hike its overall funding to $106m five years after being co-founded by Stanford Health Care.

Cloud storage provider XSky pushed its funding haul to $38m after securing the return of a Tsinghua University's fund management affiliate.

Kaiser Permanente contributed to a round that pushed the total raised by the Stanford-aligned cellular cancer therapy developer to $300m.

GV and Illumina Ventures returned to reinvest in cellular therapy developer SQZ Biotechnologies, an MIT spinout that has now raised at least $166m to date.

Dumac contributed to a round that took the total raised by the cancer screening system developer past the $130m mark.

The radiotherapy developer, which is exploiting UChicago research, has now raised $264m in funding overall.